ProQR Therapeutics N.V. sell StockNews.com
Start price
29.11.24
/
50%
€3.61
Target price
29.11.25
-
Performance (%)
-45.73%
End price
30.11.25
€1.96
Summary
This prediction ended on 30.11.25 with a price of €1.96. StockNews_com correctly predicted massive losses of -45.73% for ProQR Therapeutics N.V.. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | 16.573% | 16.573% | 11.701% |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% |
Comments by StockNews_com for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.81
11.05.24
11.05.24
-
11.05.25
11.05.25
-17.67%
12.05.25
12.05.25
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.81
12.03.24
12.03.24
-
12.03.25
12.03.25
-10.87%
13.03.25
13.03.25
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.25
11.11.23
11.11.23
-
11.11.24
11.11.24
189.12%
12.11.24
12.11.24